Woitalla D - Search Results

1

Predictors of gastric emptying in Parkinson's disease.

Goetze O, Nikodem AB, Wiezcorek J, Banasch M, Przuntek H, Mueller T, Schmidt WE, Woitalla D. Goetze O, et al. Among authors: woitalla d. Neurogastroenterol Motil. 2006 May;18(5):369-75. doi: 10.1111/j.1365-2982.2006.00780.x. Neurogastroenterol Motil. 2006. PMID: 16629864 Clinical Trial.

2

Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease.

Krüger R, Kuhn W, Müller T, Woitalla D, Graeber M, Kösel S, Przuntek H, Epplen JT, Schöls L, Riess O. Krüger R, et al. Among authors: woitalla d. Nat Genet. 1998 Feb;18(2):106-8. doi: 10.1038/ng0298-106. Nat Genet. 1998. PMID: 9462735 No abstract available.

3

High prevalence of parkinsonism after occupational exposure to lead-sulfate batteries.

Kuhn W, Winkel R, Woitalla D, Meves S, Przuntek H, Müller T. Kuhn W, et al. Among authors: woitalla d. Neurology. 1998 Jun;50(6):1885-6. doi: 10.1212/wnl.50.6.1885. Neurology. 1998. PMID: 9633752

4

Plasma levels of R- and S-salsolinol are not increased in "de-novo" Parkinsonian patients.

Müller T, Sällström Baum S, Häussermann P, Woitalla D, Rommelspacher H, Przuntek H, Kuhn W. Müller T, et al. Among authors: woitalla d. J Neural Transm (Vienna). 1998;105(2-3):239-46. doi: 10.1007/s007020050052. J Neural Transm (Vienna). 1998. PMID: 9660101 Clinical Trial.

5

Elevated plasma levels of homocysteine in Parkinson's disease.

Kuhn W, Roebroek R, Blom H, van Oppenraaij D, Przuntek H, Kretschmer A, Büttner T, Woitalla D, Müller T. Kuhn W, et al. Among authors: woitalla d. Eur Neurol. 1998 Nov;40(4):225-7. doi: 10.1159/000007984. Eur Neurol. 1998. PMID: 9813406

6

Analysis of the parkin deletion in sporadic and familial Parkinson's disease. Short communication.

Krüger R, Vieira-Säcker AM, Kuhn W, Müller T, Woitalla D, Schöls L, Przuntek H, Epplen JT, Riess O. Krüger R, et al. Among authors: woitalla d. J Neural Transm (Vienna). 1999;106(2):159-63. doi: 10.1007/s007020050148. J Neural Transm (Vienna). 1999. PMID: 10226936

7

Increased susceptibility to sporadic Parkinson's disease by a certain combined alpha-synuclein/apolipoprotein E genotype.

Krüger R, Vieira-Saecker AM, Kuhn W, Berg D, Müller T, Kühnl N, Fuchs GA, Storch A, Hungs M, Woitalla D, Przuntek H, Epplen JT, Schöls L, Riess O. Krüger R, et al. Among authors: woitalla d. Ann Neurol. 1999 May;45(5):611-7. doi: 10.1002/1531-8249(199905)45:5<611::aid-ana9>3.0.co;2-x. Ann Neurol. 1999. PMID: 10319883

8

The activity of catechol-O-methyltransferase in parkinsonian patients with "on-off fluctuations".

Woitalla D, Karwasz R, Müller T, Przuntek H, Kuhn W. Woitalla D, et al. J Neural Transm (Vienna). 2000;107(1):105-11. doi: 10.1007/s007020050009. J Neural Transm (Vienna). 2000. PMID: 10809408

9

Tolcapone increases maximum concentration of levodopa.

Müller T, Woitalla D, Schulz D, Peters S, Kuhn W, Przuntek H. Müller T, et al. Among authors: woitalla d. J Neural Transm (Vienna). 2000;107(1):113-9. doi: 10.1007/s007020050010. J Neural Transm (Vienna). 2000. PMID: 10809409 Clinical Trial.

10

Mutation analysis and association studies of the UCHL1 gene in German Parkinson's disease patients.

Wintermeyer P, Krüger R, Kuhn W, Müller T, Woitalla D, Berg D, Becker G, Leroy E, Polymeropoulos M, Berger K, Przuntek H, Schöls L, Epplen JT, Riess O. Wintermeyer P, et al. Among authors: woitalla d. Neuroreport. 2000 Jul 14;11(10):2079-82. doi: 10.1097/00001756-200007140-00004. Neuroreport. 2000. PMID: 10923647

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

127 results

Search Page